Related Experiment Video
Updated: Jul 11, 2025

Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice
Published on: February 8, 2016
A child-friendly anti-infective gummy formulation: Design, physicochemical, micromechanical, and taste sensory
Emma A Kean1, Oluwatoyin A Adeleke2
1College of Pharmacy, Faculty of Health, Dalhousie University, B3H 4R2, Halifax, NS, Canada.
Insights
A new gummy formulation (P-GDF) offers a child-friendly way to administer isoniazid for tuberculosis treatment. This edible drug delivery system improves taste and ease of use for pediatric patients.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Pediatric Medicine
Background:
- Child-friendly drug formulations are crucial for effective pediatric tuberculosis (TB) management.
- Traditional TB medications pose challenges in administration and adherence for children.
- Chewable formulations offer advantages like taste masking and ease of use.
Purpose of the Study:
- To develop and characterize a novel polymeric gummy drug formulation (P-GDF) for pediatric isoniazid delivery.
- To create an attractive, palatable, and stable formulation for improving treatment adherence in children.
Main Methods:
- Utilized a combined solid-liquid dispersion and temperature-dependent sol-gel technique to create the P-GDF.
- Incorporated isoniazid, a first-line anti-TB drug, into the gummy matrix.
- Evaluated physical, mechanical, structural, drug encapsulation, release kinetics, taste masking, and stability properties.
Main Results:
- The P-GDF (FlexiChew) was dimensionally compact, lightweight, mechanically robust, and easy to handle.
- Achieved high isoniazid encapsulation efficiency (≈101.57%) and rapid drug release (≈100% in 75 min).
- Demonstrated effective taste masking and palatability, with optimal storage conditions identified.
Conclusions:
- Successfully fabricated a child-friendly, isoniazid-loaded gummy formulation (P-GDF) for pediatric tuberculosis treatment.
- The P-GDF shows potential to enhance patient adherence and therapeutic efficacy.
- This novel formulation addresses a significant challenge in pediatric TB management.
Abstract:
The shortage of child friendly formulations constitutes a key part of the major challenges impeding the successful management of tuberculosis disease in the paediatric population. Chewable formulations are an attractive alternative to traditional preparations like tablets and suspensions owing to the possibility for taste masking, administration without water, their unique physical appeal, visually appeasing shapes, and useability in children 2 years old and above. Consequently, we designed a polymeric gummy drug formulation (P-GDF), herein referred to as the FlexiChew formulation, containing a first-line antitubercular agent, isoniazid, using a combined solid-liquid dispersion and temperature dependent sol-gel processing technique. The resulting P-GDF was visually attractive, supple, easy to handle, dimensionally compact (17.738 ± 0.779 mm height, 10.473 ± 0.944 mm width, and 8.603 ± 0.852 mm thickness), light weight (1.425 ± 0.038 g), mechanically robust (hardness = 37.260 ± 4.66 N; resilience = 0.542 ± 0.029), and potentially easy to masticate (chewiness = 30.570 ± 13.090 N; cohesiveness = 0.800 ± 0.283%; adhesiveness = 0.018 ± 0.007 mJ). It was structurally intact, effectively encapsulated isoniazid (101.565 ± 4.181%), and released it (≈100% in 75 min) following zero order and non-Fickian mechanisms in different dissolution media. Besides, it displayed efficient taste masking and palatability relative to its placebo (signal distance = 54). Short-term stability studies revealed optimal storage conditions to be under controlled ambient environments, away from direct light, and without desiccants. Thus, a child friendly isoniazid-loaded edible gummy drug formulation was successfully fabricated with the goal of improving adherence and therapeutic efficacy.
More Related Videos
Related Concept Videos
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Influencing Drug Absorption: Pharmaceutical Parameters

